Answer
It is licensed as an additional test for suspected breast lesions when recommended initial assessments are inconclusive. A negative result does not exclude cancer, and it is not indicated for staging.
Sources for this answer
- MYOVIEW 230 micrograms kit for radiopharmaceutical preparationemc · SmPC Current selected SmPC · Version 3